Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
SYNLAB

November 2025

SYNLAB Market Share Analysis for November 2025

SYNLAB Group is an international medical diagnostics provider headquartered in Munich, Germany. SYNLAB is leading in diagnostic services and specialty testing in Europe.
Domainsynlab.be
Year Founded1998
Employees> 10001
Annual Revenue> $1B
synlab.be
SYNLAB
SYNLAB (including company regionals)
  • synlab.be
    synlab.be
See more website traffic and engagement information

SYNLAB Revenue up to November 2025 is > 1B

revenue generated by SYNLAB top domains

SYNLAB top domains revenue over 3 years

Revenue for SYNLAB top domains


Total visits to SYNLAB's top domains

Understand SYNLAB market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in SYNLAB's top domains

Analyze SYNLAB engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on SYNLAB's top domains

See how SYNLAB keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by SYNLAB

These are the website technologies, by industry, used by SYNLAB top domains

Payment & Currencies (7)

Advertising (4)

PubMatic

PubMatic

Widget (4)

reCAPTCHA

reCAPTCHA

Content Management System (3)

Joomla

Joomla

More Technologies

9

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from SYNLAB

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSynlab launches EDIT-B.To significantly reduce this diagnosis wondering, ALCEDIAG and SYNLAB are announcing, on the occasion of the 31 st EPA congress, the availability of EDIT-B™, the world's first CE-marked in-vitro blood test designed to differentiate BD from depression.

See all SYNLAB signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.